Today

Agents

Chat

Arena

Discover

More

App

Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212 - ACET News | Rallies

Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212

ACET•2026-08-27

FDA clears IND application for ADI-212

Adicet Bio, Inc. said the FDA has cleared its IND application for ADI-212.
The company said it expects to begin Phase 1 enrollment for ADI-212 in mCRPC in Q4 2026.

Related News

Avantor amends filing to set executive Benoit Gourdier departure for Oct. 14, 2026

AVTR•2026-08-27

BeOne Medicines President, COO Wu Xiaobin disposes of ADSs worth $106,400

ONC•2026-08-27

Nvidia to present at Goldman Sachs Communacopia + Technology Conference

•

2026-08-27

Element Solutions terminates merger agreement with Solstice Advanced Materials

ESI•2026-08-27

McEwen affiliate McEwen Copper closes USD 240 million term loan for Los Azules project

MUX•2026-08-27